Breaking News


SkinMedica, Mass General Hospital Form Accord

October 2, 2012


• SkinMedica will collaborate with Massachusetts General Hospital (MGH) for the research and development of pigmentation products, the Carlsbad, CA company announced. The exclusive agreement involves screening and evaluating a library of roughly 40,000 natural extracts made available by the National Cancer Institute for potential applications in pigmentation.

The principal investigator for this collaborative effort is Dr. David Fisher, chief of the Massachusetts General Hospital Department of Dermatology, director of the MGH Cutaneous Biology Research Center and Director of the Melanoma Center at MGH. He is also the Edward Wigglesworth Professor of Dermatology at Harvard Medical School and past president of the Society for Melanoma Research.

Mary Fisher, CEO of SkinMedica. said Dr. Fisher’s “expertise in pigment and the skin’s environmental responses will be invaluable as we together to pursue novel approaches for patients with a variety of pigment related concerns.”

More info: www.skinmedica.com
blog comments powered by Disqus
  • Long Term Sustainability In the Nonwovens Market

    Long Term Sustainability In the Nonwovens Market

    August 23, 2016
    Learn more at Cleaning Products USA, Nov. 9-11, 2016

  • Fro Yo!

    Fro Yo!

    Tom Branna, Editorial Director||August 22, 2016
    Project Beauty dishes out Hairgurt, a line of vitamin-rich hair shampoos and conditioning masques.

  • TLC for Those Who Need It Most

    TLC for Those Who Need It Most

    Christine Esposito, Associate Editor||August 22, 2016
    New curriculum debuting at Bellus Academy helps estheticians treat a population that needs TLC.